Redsense Medical posted record 2024 sales and its first positive annual result, driven by U.S. market strength and product innovation. Major investments and new product launches set the stage for 2025 growth, despite ongoing regulatory and market risks.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.